COPD Therapeutics

The objective of COPD therapeutics is to enhance a patient's functional status and quality by protecting optimal lung function, enhancing indications, and keeping the recurrence of COPD exacerbations. At present, no medicines aside from lung transplantation have been appeared to significantly enhance lung function or decrease mortality; however, oxygen therapy and smoking cessation may decrease mortality. Once the diagnosis of COPD is established, it is essential to educate the patient about the sickness and to empower their active interest in treatment. Bronchodilators are the foundation of any COPD treatment regimen. They work by enlarging aviation routes, accordingly diminishing airsac protection. Pulmonary Conferences provides a multidisciplinary to pulmonology researchers.

  • Smoking Cessation
  • Bronchodilators
  • Corticosteroids
  • Oxygen Therapy
  • Pulmonary Rehabilitation

Related Conference of COPD Therapeutics

August 17-18, 2020

10th International Conference on COPD and Lungs

Prague, Czech Republic
October 19-20, 2020

International Congress and Expo on Pulmonology

Manila, Philippines
October 29-30, 2020

International Conference on Lung Diseases

Cape Town, South Africa
November 18-19, 2020

International Conference on Asthma and Allergy

Lisbon, Portugal
December 07-08, 2020

8th Annual Congress on Pulmonary and Critical Care

Tokyo, Japan

COPD Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in